‌

US Patent 10588949 Factor IX polypeptide formulations

Patent 10588949 was granted and assigned to Bioverativ on March, 2020 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Something went wrong.

Try refreshing the page.

Find more entities like US Patent 10588949 Factor IX polypeptide formulations

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo